Skip to content
July 22, 2024

Equity.Guru

Investment information for the new generation

Search

Search Results for: atai.q

This week, news from the psychedelic sector has been dominated by patent applications and earnings being released. Here’s the run down of this week’s news. Cybin (CYBN.NE) It’s been…
Shorter trips Remember early YouTube days when (insert activity here ______ on salvia) were some of the most popular videos on the internet? Well, it turns out salvia is…
Big ass IPO? Not really… ‘Shares soar as Atai Life Sciences IPO’s on the Nasdaq’ is the story being spun around Atai’s (ATAI.Q) first crack at going public last…
Psychedelics have showed tremendous potential in treating neurological conditions such as major depressive disorder, PTSD, ALS, and generalized anxiety. Investors jumped on the opportunity, sending market values skyrocketing. It’s…
Whether you’re curious about taking a psychedelics investment trip or a tie-dyed-in-the-wool public market backer, psychedelics conferences are the best way to keep on top of industry advances and…
Naturally occurring psychedelic compounds such as DMT in ayahuasca, psilocybin in magic mushrooms, salvinorum A found in the salvia divinorum mint species, mescaline from peyote cacti and the scolpolamine…
Interest in the psychedelic market is as high as Matt Gaetz and Joel Greenberg on a night out, but the accompanying FOMO has the potential to muddy the market,…
The psychedelics space is one of the hottest investment trips in the public markets today. Embryonic, wide open to possibility and with mounting scientific evidence of psychedelics’ healing properties,…
Revive Therapeutics (RVV.C) joined the AdvisorShares Psychedelics ETF (PSIL.NYSE) today, in time for its launch, according to a press release.   If you’re not entirely sure what an ETF…
It seems like every few days I stumble across a new name in the psychedelics industry I hadn’t heard before. Usually smaller deals just getting off the ground. But,…